Trulieve Cannabis Corp. (TCNNF) Q1 2026 Earnings Call Transcript
Trulieve Cannabis Corp. (TCNNF) Q1 2026 Earnings Call Transcript
Trulieve: Q4 Results Show Strong Balance Sheet, But Sector Uncertainty Remains
Trulieve reported an increase in revenue, free cash flow, and lower debt for Q4 2025. The company received a provisional license to open medical dispensaries in Texas. The cannabis sector remains weak due to uncertainty over rescheduling.
Trulieve Cannabis Corp. (TCNNF) Q4 2025 Earnings Call Transcript
Trulieve Cannabis Corp. (TCNNF) Q4 2025 Earnings Call Transcript
3 Marijuana Stocks To Watch That Could Make A Profit In 2026
The cannabis industry has reached the same fork in the road when it comes to reform. The recent Farm Bill, which allowed for certain hemp products to be produced and sold, is essentially no more. Yet state laws may help to protect the existence of hemp industries. On top of this, there is yet another push calling for the end of cannabis prohibtion. This is causing some flare in the sector on what could happen in the near future.
Here Is What They Are Not Telling You About Marijuana Stocks
The growth of the cannabis industry is nothing short of amazing. Marijuana usage of all kinds has been around for many years. But only over the last several years have things begun to expand and evolve. From an investor's standpoint, some went all in and built businesses. Then you have those who invest in fractions of the company for those that are publicly traded. Marijuana stocks offer a shorter route to investing in this sector.
Trulieve Cannabis Corp. (TCNNF) Q3 2025 Earnings Call Transcript
Trulieve Cannabis Corp. (OTCQX:TCNNF) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Christine Hersey - Vice President of Investor Relations Kimberly Rivers - Founder, Chairman & CEO Jan Reese - Chief Financial Officer Conference Call Participants Luke Hannan - Canaccord Genuity Corp., Research Division Russell Stanley - Beacon Securities Limited, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Brenna Cunnington - ATB Capital Markets Inc., Research Division Aaron Grey - Alliance Global Partners, Research Division Andrew Semple - Ventum Financial Corp., Research Division Presentation Operator Good morning, everyone, and welcome to the Trulieve Cannabis Corporation Third Quarter 2025 Financial Results Conference Call. My name is Danielle, and I will be your conference operator today.
Trulieve Cannabis Corp. (TCNNF) Q2 2025 Earnings Call Transcript
Trulieve Cannabis Corp. (OTCQX:TCNNF) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Christine Hersey - Vice President of Investor Relations Kimberly Rivers - Founder, Chairman & CEO Ryan Blust - Interim CFO, Controller & Director of Financial Reporting Conference Call Participants Aaron Thomas Grey - Alliance Global Partners, Research Division Brenna Cunnington - Unidentified Company Luke Hannan - Canaccord Genuity Corp., Research Division Nicholas Steven Anderson - ROTH Capital Partners, LLC, Research Division Russell Stanley - Beacon Securities Limited, Research Division Operator Good morning, everyone, and welcome to the Trulieve Cannabis Corporation Second Quarter 2025 Financial Results Conference Call. My name is Keith, and I will be your conference operator today.
Trulieve: Well-Positioned In A Struggling Industry
Trulieve (TCNNF) stands out among cannabis peers due to a healthier balance sheet amid industry-wide debt concerns. This should position them to expand into other markets on favorable terms, while competitors go bankrupt or contract operations. The company's heavy concentration in Florida presents some geographic risk, limited by the state's recent refusal to allow adult-use cannabis.
Trulieve Cannabis Corp. (TCNNF) Q1 2025 Earnings Call Transcript
Trulieve Cannabis Corp. (OTCQX:TCNNF) Q1 2025 Results Conference Call May 7, 2025 8:30 AM ET Company Participants Christine Hersey - Vice President of Investor Relations Kim Rivers - Chief Executive Officer Ryan Blust - Interim Chief Financial Officer Conference Call Participants Luke Hannan - Canaccord Genuity Aaron Grey - Alliance Global Partners Russell Stanley - Beacon Securities Frederico Gomes - ATB Capital Markets Bill Kirk - MKM Partners Andrew Semple - Echelon Capital Markets Operator Good morning, everyone, and welcome to the Trulieve Cannabis Corporation First Quarter 2025 Financial Results Conference Call. My name is Debbie, and I will be your conference operator for today.
Trulieve Cannabis Corp. (TCNNF) Q4 2024 Earnings Call Transcript
Trulieve Cannabis Corp. (OTCQX:TCNNF) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Christine Hersey - VP, IR Kim Rivers - CEO Wes Getman - CFO Conference Call Participants Luke Hannan - Canaccord Genuity Donangelo Volpe - Beacon Aaron Grey - AGP Andrew Semple - Echelon Capital Markets Brenna Cunnington - ATB Capital Markets Operator Good morning, everyone, and welcome to the Trulieve Cannabis Corporation Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Andrea, and I will be your conference operator for today.
Trulieve Cannabis Corp. (TCNNF) Q3 2024 Earnings Call Transcript
Trulieve Cannabis Corp. (OTCQX:TCNNF) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Christine Hersey - Vice President, Investor Relations Kim Rivers - Founder, Chairman, Chief Executive Officer Wes Getman - Chief Financial Officer Conference Call Participants Luke Hannan - Canaccord Genuity Frederico Gomes - ATB Capital Markets Aaron Grey - Alliance Global Partners Russell Stanley - Beacon Securities Eric Des Lauriers - Craig-Hallum Capital Group Mike Regan - Excelsior Equities Andrew Semple - Ventum Financial Operator Good morning, everyone, and welcome to the Trulieve Cannabis Corporation Third Quarter 2024 Financial Results Conference Call. My name is Darvin, and I will be the conference operator today.
Trulieve: Regulatory Developments And Growth Acceleration Could Trigger Significant Upside
Initiating coverage on Trulieve Cannabis with a "Buy" rating, driven by potential regulatory catalysts and strong fundamentals, over a 24-month investment horizon. Florida's potential legalization of recreational cannabis and cannabis rescheduling to Schedule III are key growth catalysts, with significant revenue implications. Trulieve's strong financials, including robust EBITDA margins, low leverage, and healthy cash flow, support growth despite regulatory uncertainties.
